Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti–PD-1 Therapy
Authors:
- Natalia SzóstakNSNatalia Szóstak
- Luiza HandschuhLHLuiza Handschuh
- Anna Samelak-CzajkaASAnna Samelak-Czajka
- Katarzyna TomelaKTKatarzyna Tomela
- Bernadeta PietrzakBPBernadeta Pietrzak
- Marcin SchmidtMarcin Schmidt
- Łukasz GalusŁGŁukasz Galus
- Jacek MackiewiczJMJacek Mackiewicz
- Andrzej MackiewiczAndrzej Mackiewicz
- Piotr KozlowskiPiotr Kozlowski
- Anna PhilipsAnna Philips
Open Access
- 5 February 2024
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Immunology Research
- Vol. 12 (4) , 427-439
Abstract
Recent research indicates that gut microbiota may be vital in the advancement of melanoma. In this study, we found that melanoma patients exhibited a distinct gut mycobiota structure compared with healthy participants. Candida albicans, Candida dubliniensis, and Neurospora crassa were more abundant in samples from patients with melanoma, whereas Saccharomyces cerevisiae and Debaryomyces hansenii were less abundant. During anti–PD-1 treatment, the relative amount of Malassezia restricta and C. albicans increased. A higher level of Saccharomyces paradoxus was associated with a positive response to anti–PD-1 treatment, whereas a higher level of Tetrapisispora blattae was associated with a lack of clinical benefits. High levels of M. restricta and C. albicans, elevated serum lactate dehydrogenase, and being overweight were linked to increased risk of melanoma progression and poorer response to anti–PD-1 treatment. Thus, this study has revealed melanoma-associated mycobiome dysbiosis, characterized by altered fungal composition and fungi species associated with a higher risk of melanoma progression, identifying a role for the gut mycobiome in melanoma progression.Keywords
All Related Versions
Funding Information
- Narodowe Centrum Nauki (2021/41/B/NZ9/03765)
- Narodowe Centrum Badań i Rozwoju (POIR.04.01.02-00-0025/17-00)
This publication has 55 references indexed in Scilit:
- The role of melanin pigment in melanomaExperimental Dermatology, 2014
- Risk factors: Riddle of the raysNature, 2014
- Do inflammatory pathways drive melanomagenesis?Experimental Dermatology, 2014
- Is there new hope for therapeutic matrix metalloproteinase inhibition?Nature Reviews Drug Discovery, 2014
- Kraken: ultrafast metagenomic sequence classification using exact alignmentsGenome Biology, 2014
- The Malassezia Genus in Skin and Systemic DiseasesClinical Microbiology Reviews, 2012
- Candida albicans enhances experimental hepatic melanoma metastasisClinical & Experimental Metastasis, 2009
- Anti-tumor metastatic activity of β-glucan purified from mutated Saccharomyces cerevisiaeInternational Immunopharmacology, 2008
- Beta glucan induces proliferation and activation of monocytes in peripheral blood of patients with advanced breast cancerInternational Immunopharmacology, 2007
- Induction of Oxidative Stress Response by the Mycotoxin Patulin in Mammalian CellsToxicological Sciences, 2006